Bacterial infiltration in structural heart valve disease.

bacterial infiltration calcification metagenome analysis polymicrobial structural valvular heart disease transcatheter aortic valve implantation

Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 26 10 2018
revised: 01 02 2019
accepted: 04 02 2019
medline: 20 3 2019
pubmed: 20 3 2019
entrez: 20 3 2019
Statut: ppublish

Résumé

The pathology of structural valvular heart disease (sVHD) ranges from basic diseases of rheumatologic origin to chronic degenerative remodeling processes after acute bacterial infections. Molecular genetic methods allow detection of the complete microbial spectrum in heart valve tissues independent of microbiological cultivation. In particular, whole-metagenome analysis is a sensitive and highly specific analytical method that allows a deeper insight into the pathogenicity of the diseases. In the present study we assessed the pathogen spectrum in heart valve tissue from 25 sVHD patients using molecular and microbiological methods. Twenty-five sVHD patients were selected randomly from an observational cohort study (March 2016 to January 2017). The explanted native heart valves were examined using microbiological methods and immunohistological structural analysis. In addition, the bacterial metagenome of the heart valve tissue was determined using next-generation sequencing. The use of sonication as a pretreatment of valve tissue from 4 sVHD patients permitted successful detection of Clostridium difficile, Enterococcus faecalis, Staphylococcus saccharolyticus, and Staphylococcus haemolyticus using microbial cultivation. Histological staining revealed intramural localization. Metagenome analysis identified a higher rate of bacterial infiltration in 52% of cases. The pathogen spectrum included both gram-positive and gram-negative bacteria. Microbiological and molecular biological studies are necessary to detect the spectrum of bacteria in a calcified heart valve. Metagenome analysis is a valid method to gain new insight into the polymicrobial pathophysiology of sVHD. Our results suggest that an undetected proportion of sVHD might be triggered by chronic inflammation or influenced by secondary bacterial infiltration.

Identifiants

pubmed: 30885626
pii: S0022-5223(19)30451-9
doi: 10.1016/j.jtcvs.2019.02.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116-124.e4

Investigateurs

Miriam Gruhle (M)
Marion Albert (M)
Maximilian Luehr (M)
Maximilian Pichlmaier (M)
Arne C Rodloff (AC)
Kristin Reiche (K)
Theresa Kraft (T)
Friedemann Horn (F)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Andreas Oberbach (A)

Department of Cardiac Surgery, Ludwig-Maximilians-University, Munich, Germany; Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; Division of Gastroenterology and Hepatology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Md. Electronic address: Andreas.Oberbach@medizin.uni-leipzig.de.

Maik Friedrich (M)

Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; Institute of Clinical Immunology, University of Leipzig, Leipzig, Germany.

Stefanie Lehmann (S)

Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; Department of Internal Medicine, University of Leipzig, Leipzig, Germany.

Nadine Schlichting (N)

Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; Department of Visceral, Transplantation, Thoracic and Vascular Surgery, Leipzig University Hospital, Leipzig, Germany.

Yvonne Kullnick (Y)

Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.

Sandra Gräber (S)

Institute for Medical Microbiology and Epidemiology of Infectious Diseases, Leipzig University Hospital, Leipzig, Germany.

Tilo Buschmann (T)

Department of Diagnostics, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.

Christian Hagl (C)

Department of Cardiac Surgery, Ludwig-Maximilians-University, Munich, Germany; Munich Heart Alliance, Partner Site German Center for Cardiovascular Disease (DZHK), Munich, Germany.

Erik Bagaev (E)

Department of Cardiac Surgery, Ludwig-Maximilians-University, Munich, Germany.

Classifications MeSH